ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Scientist II, Conjugation Development at Vaxcyte - ApplyBlast

Scientist II, Conjugation Development

Vaxcyte

4 months ago

3.9 on Glassdoor

San Carlos, California, United States

Onsite

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Vaxcyte is seeking a Scientist II to lead and execute experimental activities for its pneumococcal conjugate vaccine program and other pipeline projects. The role focuses on developing, optimizing, and scaling conjugation processes, including preparation, purification, and analytical characterization of polysaccharide‑protein conjugates, while collaborating with cross‑functional teams and external partners.

Responsibilities

Lead and execute conjugation process development experiments
Optimize multi‑step synthesis and purification of protein‑polysaccharide conjugates
Serve as subject matter expert during tech transfer to contract manufacturing organizations

Skills

Qualifications

PhD in chemistry, biochemistry, or related fieldMSBS

About Vaxcyte

vaxcyte.com

Headquarters

San Carlos, California, United States

Company Size

51-200 employees

Founded

2013

View Profile

Vaxcyte is a clinical-stage vaccine innovation company dedicated to eliminating bacterial infections — including invasive pneumococcal disease, Group A Strep, and Shigella — using advanced chemistry and a proprietary cell-free protein synthesis platform. Its lead programs, VAX-31 (a 31-valent PCV) and VAX-24 (a 24-valent PCV), are being evaluated in Phase 3 trials for the prevention of invasive pneumococcal disease, with additional early-stage candidates targeting Group A Strep and Shigella. Vaxcyte is also investing up to $1 billion in U.S. biomanufacturing expansion to support scalable vaccine production.